Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 22:14 UTC |
Wicks Timothy ADirector
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001339919-26-000002 · wk-form4_1791929660.xml · nonDerivative · entry 1 Wicks Timothy A · CIK 0001339919 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,684 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 22:13 UTC |
Lofton Kevin EDirector
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001468818-26-000004 · wk-form4_1791929588.xml · nonDerivative · entry 1 Lofton Kevin E · CIK 0001468818 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,573 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 22:12 UTC |
GROSSMAN D KEITHDirector
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001218702-26-000003 · wk-form4_1791929517.xml · nonDerivative · entry 1 GROSSMAN D KEITH · CIK 0001218702 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,684 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUS. Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 22:10 UTC |
Endicott David J.Director
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001532133-26-000004 · wk-form4_1791929430.xml · nonDerivative · entry 1 Endicott David J. · CIK 0001532133 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,795 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 22:09 UTC |
EISENBERG GLENN ADirector
|
GrantCommon Stock | 11,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001222831-26-000015 · wk-form4_1791929357.xml · nonDerivative · entry 1 EISENBERG GLENN A · CIK 0001222831 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,684 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the one-year anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| October 01, 2026 Filed Oct 5, 2026 20:27 UTC |
Denton Sheila A.SVP, Gen. Counsel & Corp. Sec.
|
GrantCommon Stock | 58,939 | $0.00 | $0.00 |
DisclosureSEC source: 0001995298-26-000009 · wk-form4_1791232056.xml · nonDerivative · entry 1 Denton Sheila A. · CIK 0001995298 · SVP, Gen. Counsel & Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,939 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 21:38 UTC |
Dallara QueDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 31,350 | $18.15 | $569,002.50 |
DisclosureSEC source: 0001756652-26-000004 · wk-form4_1785879529.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 884,749 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 21:44 UTC |
Wills Courtney NelsonSVP, Gen. Counsel, Corp. Sec.
|
Tax withholdingCommon Stock | 1,762 | $18.15 | $31,980.30 |
DisclosureSEC source: 0002110477-26-000004 · wk-form4_1785879853.xml · nonDerivative · entry 1 Wills Courtney Nelson · CIK 0002110477 · SVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,384 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 21:40 UTC |
Dianaty AliEVP Ch. Prod. & Tech Officer
|
Tax withholdingCommon Stock | 8,012 | $18.15 | $145,417.80 |
DisclosureSEC source: 0002111492-26-000004 · wk-form4_1785879631.xml · nonDerivative · entry 1 Dianaty Ali · CIK 0002111492 · EVP Ch. Prod. & Tech Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 315,158 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 23:10 UTC |
Spooner ChadEVP, Chief Financial Officer
|
Tax withholdingCommon Stock | 23,301 | $17.67 | $411,728.67 |
DisclosureSEC source: 0002111465-26-000004 · wk-form4_1785366625.xml · nonDerivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 362,707 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 28, 2026 Filed Jul 29, 2026 23:08 UTC |
Chandrasena GillianSVP, Chief HR Officer
|
Tax withholdingCommon Stock | 2,099 | $17.67 | $37,089.33 |
DisclosureSEC source: 0002111466-26-000004 · wk-form4_1785366521.xml · nonDerivative · entry 1 Chandrasena Gillian · CIK 0002111466 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,745 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:44 UTC |
Gyurci JohnVP, Chief Accounting Officer
|
GrantCommon Stock | 24,244 | $0.00 | $0.00 |
DisclosureSEC source: 0001850688-26-000003 · wk-form4_1783374275.xml · nonDerivative · entry 1 Gyurci John · CIK 0001850688 · VP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,941 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 375 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:37 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 297,618 | $0.00 | $0.00 |
DisclosureSEC source: 0001756652-26-000002 · wk-form4_1783373854.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 916,099 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 1,727 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:45 UTC |
Wills Courtney NelsonSVP, Gen. Counsel, Corp. Sec.
|
GrantCommon Stock | 22,057 | $0.00 | $0.00 |
DisclosureSEC source: 0002110477-26-000002 · wk-form4_1783374354.xml · nonDerivative · entry 2 Wills Courtney Nelson · CIK 0002110477 · SVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,146 F4 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:45 UTC |
Wills Courtney NelsonSVP, Gen. Counsel, Corp. Sec.
|
GrantCommon Stock | 60,730 | $0.00 | $0.00 |
DisclosureSEC source: 0002110477-26-000002 · wk-form4_1783374354.xml · nonDerivative · entry 1 Wills Courtney Nelson · CIK 0002110477 · SVP, Gen. Counsel, Corp. Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,089 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 296 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:43 UTC |
Chandrasena GillianSVP, Chief HR Officer
|
GrantCommon Stock | 14,705 | $0.00 | $0.00 |
DisclosureSEC source: 0002111466-26-000002 · wk-form4_1783374194.xml · nonDerivative · entry 2 Chandrasena Gillian · CIK 0002111466 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 174,844 F4 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:43 UTC |
Chandrasena GillianSVP, Chief HR Officer
|
GrantCommon Stock | 29,483 | $0.00 | $0.00 |
DisclosureSEC source: 0002111466-26-000002 · wk-form4_1783374194.xml · nonDerivative · entry 1 Chandrasena Gillian · CIK 0002111466 · SVP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,139 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 891 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:39 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 36,762 | $0.00 | $0.00 |
DisclosureSEC source: 0002111492-26-000002 · wk-form4_1783373946.xml · nonDerivative · entry 2 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 323,170 F4 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:39 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 94,550 | $0.00 | $0.00 |
DisclosureSEC source: 0002111492-26-000002 · wk-form4_1783373946.xml · nonDerivative · entry 1 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,408 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. F3 · balance_after: Includes 600 shares acquired under MMED's 2026 Employee Stock Purchase Plan on June 30, 2026. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:40 UTC |
Spooner ChadEVP, Chief Financial Officer
|
GrantCommon Stock | 22,057 | $0.00 | $0.00 |
DisclosureSEC source: 0002111465-26-000002 · wk-form4_1783374050.xml · nonDerivative · entry 2 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 386,008 F3 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest on the third anniversary of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 21:40 UTC |
Spooner ChadEVP, Chief Financial Officer
|
GrantCommon Stock | 94,550 | $0.00 | $0.00 |
DisclosureSEC source: 0002111465-26-000002 · wk-form4_1783374050.xml · nonDerivative · entry 1 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,951 F1 · shares: Represents the grant of restricted stock units ("RSUs") pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan that vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date. F2 · balance_after: Includes shares of common stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| March 25, 2026 Filed Mar 27, 2026 20:31 UTC |
Dallara QueDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 4,809 | $16.31 | $78,434.79 |
DisclosureSEC source: 0001628280-26-021752 · wk-form4_1774643481.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 616,754 F1 · shares: Represents shares of Common Stock that have been withheld by MiniMed Group, Inc. to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of Restricted Stock Units ("RSUs"). F2 · balance_after: Includes shares of Common Stock to be issued in connection with the vesting of one or more RSUs. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:27 UTC |
Gyurci JohnSee Remarks
|
GrantCommon Stock | 15,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017832 · wk-form4_1773444433.xml · nonDerivative · entry 1 Gyurci John · CIK 0001850688 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,322 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest in three equal installments on January 26, 2027, January 26, 2028, and January 26, 2029. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest in three equal installments on January 26, 2027, January 26, 2028, and January 26, 2029. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 22,892 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 6 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,892 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F9 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027. F9 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 10, 2026 and March 10, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 51,044 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 5 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,044 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F8 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F8 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 80,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 4 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,842 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F7 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F7 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 57,239 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 3 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,239 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 127,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 2 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,609 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:23 UTC |
Dallara QueDirector · Chief Executive Officer
|
GrantCommon Stock | 281,937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017827 · wk-form4_1773444228.xml · nonDerivative · entry 1 Dallara Que · CIK 0001756652 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,937 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Chandrasena GillianSee Remarks
|
GrantCommon Stock | 11,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017831 · wk-form4_1773444403.xml · nonDerivative · entry 5 Chandrasena Gillian · CIK 0002111466 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,486 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F8 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F8 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Chandrasena GillianSee Remarks
|
GrantCommon Stock | 11,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017831 · wk-form4_1773444403.xml · nonDerivative · entry 4 Chandrasena Gillian · CIK 0002111466 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,486 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F7 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F7 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Chandrasena GillianSee Remarks
|
GrantCommon Stock | 58,825 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017831 · wk-form4_1773444403.xml · nonDerivative · entry 3 Chandrasena Gillian · CIK 0002111466 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,825 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Chandrasena GillianSee Remarks
|
GrantCommon Stock | 28,116 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017831 · wk-form4_1773444403.xml · nonDerivative · entry 2 Chandrasena Gillian · CIK 0002111466 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,116 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 3, 2027 and March 3, 2028 F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in two equal installments on March 3, 2027 and March 3, 2028 F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Chandrasena GillianSee Remarks
|
GrantCommon Stock | 19,852 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017831 · wk-form4_1773444403.xml · nonDerivative · entry 1 Chandrasena Gillian · CIK 0002111466 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,852 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 5,743 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 6 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,743 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F9 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F9 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 13,646 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 5 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,646 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F8 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F8 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 5,151 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 4 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,151 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F7 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F7 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 11,486 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 3 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,486 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 955 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 2 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:26 UTC |
Wills Courtney NelsonSee Remarks
|
GrantCommon Stock | 18,082 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017830 · wk-form4_1773444373.xml · nonDerivative · entry 1 Wills Courtney Nelson · CIK 0002110477 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,082 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 2,444 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 8 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,444 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F11 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on October 28, 2026, October 28, 2027 and October 29, 2028. F11 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on October 28, 2026, October 28, 2027 and October 29, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 11,563 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 7 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,563 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F10 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on December 6, 2026. F10 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on December 6, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 35,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 6 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,448 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F9 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F9 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 33,684 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 5 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,684 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F8 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F8 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 29, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 14,628 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 4 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,628 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F7 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F7 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 31, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 35,448 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 3 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,448 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 46,989 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 2 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,989 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on April 30, 2027. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:25 UTC |
Dianaty AliSee Remarks
|
GrantCommon Stock | 11,054 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017829 · wk-form4_1773444329.xml · nonDerivative · entry 1 Dianaty Ali · CIK 0002111492 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,054 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F3 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on December 6, 2026. F3 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the 2026 MiniMed Group, Inc. Long Term Incentive Plan (the "LTIP") and vest on December 6, 2026. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:24 UTC |
Spooner ChadEVP, Chief Financial Officer
|
GrantCommon Stock | 70,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017828 · wk-form4_1773444267.xml · nonDerivative · entry 3 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,896 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F6 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F6 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest on July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
| March 11, 2026 Filed Mar 13, 2026 23:24 UTC |
Spooner ChadEVP, Chief Financial Officer
|
GrantCommon Stock | 127,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001628280-26-017828 · wk-form4_1773444267.xml · nonDerivative · entry 2 Spooner Chad · CIK 0002111465 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,609 F1 · date: In connection with MMED's separation from Medtronic plc ("Medtronic") effective March 9, 2026 (the "Separation"), as further described in MMED's current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the "Medtronic Awards") were converted into time-vesting restricted stock units denominated in shares of MMED's common stock ("MMED RSUs") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the "EMA"). F2 · date: Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the "Equity Award Conversion"). F5 · shares: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F5 · price: Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028. F4 · balance_after: Includes shares to be issued in connection with the vesting of one or more restricted stock units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.